# 2026-01940: Bulk Manufacturer of Controlled Substances Application: Promega Corporation

2026-01940, Bulk Manufacturer of Controlled Substances Application: Promega Corporation, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-02-02, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 3, 2026. Such persons may also file a written request for a hearing on the application on or before April 3, 2026. (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-01940
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-01940
- Title: Bulk Manufacturer of Controlled Substances Application: Promega Corporation
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 4634
- Published: 2026-02-02
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before April 3, 2026. Such persons may also file a written request for a hearing on the application on or before April 3, 2026.
- Comments close: 2026-04-03
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## Summary

Promega Corporation wants to make large amounts of psilocybin and psilocyn, two controlled substances, to sell as ingredients for medicines. People and companies involved with these drugs can share their thoughts or ask for a hearing by April 3, 2026. This move could boost medicine development but also means Promega will handle some powerful substances under strict rules.

## Abstract

Promega Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- Promega Seeks to Make Schedule I APIs: benefit, low. On January 7, 2026, Promega Corporation (3075 Sub Zero Parkway, Fitchburg, Wisconsin) applied to be registered to bulk manufacture psilocybin (code 7437) and psilocyn (code 7438), both listed as Schedule I. The company says it plans to make these substances as Active Pharmaceutical Ingredients (API…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-01940 on federalregister.gov](https://www.federalregister.gov/documents/2026/02/02/2026-01940/bulk-manufacturer-of-controlled-substances-application-promega-corporation)
- [2026-01940 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-02-02/pdf/2026-01940.pdf)

## Related
- [Previous: 2026-01939, National Library of Medicine; Notice of Partially Closed Meeting](https://policyrisk.com/federal-register/2026-01939)
- [Next: 2026-01941, Center for Scientific Review; Notice of Closed Meeting](https://policyrisk.com/federal-register/2026-01941)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-01940 (as of 2026-06-08).
